NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Hoffmann-La Roche
AstraZeneca
AstraZeneca
Revolution Medicines, Inc.
AstraZeneca
AstraZeneca
AstraZeneca
Sanofi
University Health Network, Toronto
Hoffmann-La Roche
Numab Therapeutics AG
Intensity Therapeutics, Inc.
Advaxis, Inc.
Novartis
Takeda
Ludwig Institute for Cancer Research
UCB Pharma
Takeda
Duke University
Eli Lilly and Company
Mereo BioPharma
GlaxoSmithKline
University of Florida
Dartmouth-Hitchcock Medical Center
Sunesis Pharmaceuticals
Celgene
Sunesis Pharmaceuticals
Daiichi Sankyo
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
Merck KGaA, Darmstadt, Germany
Duke University
Bristol-Myers Squibb
AstraZeneca
Pfizer
Pfizer
Sanofi
AstraZeneca
Eli Lilly and Company